A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to researchers at UNIST. Led by Professor Joo Hun Kang in the Department of Biomedical ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

A new study suggests wrist-worn sleep trackers may help predict depression relapse weeks early—explore what this means for ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

For the budding alcoholic/addict in recovery, relapse is all too often a nano second away. Even for the well seasoned soul who has practiced a clean and sober lifestyle for many years, relapse may be ...

“How many mental health diagnoses in clinical practice result from misdiagnosed withdrawal?” The question orients an editorial published last week in Psychotherapy and Psychosomatics concerning a ...

John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in Frontiers in Public Health, “Long-term relapse: ...

Testicular cancer is one of the most common cancers affecting young men, especially those between the ages of 20 and 40.

Adding belzutifan to pembrolizumab after kidney cancer surgery cuts recurrence risk by 28%, helping high-risk patients stay ...